Medixon 500mg powder for injection
Ferron Par Pharmaceuticals
Ingredients in every 8 ml
Each package contains
|ATC Level 1||H - Systemic hormonal preparations; excluding sex hormones and insulins|
|ATC Level 2||H02 - Corticosteroids for Systemic Use|
|ATC Level 3||H02A - Corticosteroids for Systemic Use; Plain|
0 TO 18 YEARS OLD
Infant and children:
Adrenocortical insufficiency: Intramuscular, 0.18 mg (base) per kg of body weight or 3.33 mg (base) per square meter of body surface area daily (in three divided doses) every third day
Acute spinal cord injury treatment: intravenous, 30 mg (base) per kg of body weight administered over a 15 minutes, followed after 45 minutes by a continuous infusion of 5.4 mg per kg of body weight per hour, for 23 hours.
Adjunctive treatment in patients with Pneumocystis carinii pneumonia associated with AIDS: Children up to 14 years of age; dosage has not been established. Children 14 years of age or older; see Adults and adolescent dose.
IM or IV injection:
Reconstitute powder by adding solvent (containing benzyl alcohol 0.9%), mix homogeneously. Direct intravenously can be given at least 1 minute or can be given by intravenously infusion in dextrose 5%, NaCl 0.9% or dextrose 5% in NaCl 0.9% for at least 30 minutes. The solution is stable physically and chemically for 48 hours
Endocrine disorders, allergic disorders, collagen disorders, dermatologic disorders, gastrointestinal disorders, hematologic disorders, hepatic diseases, nonrheumatoid inflammation, neoplastic diseases, nephrotic syndrome, neurologic diseases, neurotrauma, ophthalmic disorders, pericarditis, nasal polyps, respiratory disorders.